Augmenting Flortaucipir Dosimetry Estimates

Completed · Phase 1

Conditions studied: Alzheimer's Disease

In brief

This study will obtain data from urine in subjects administered flortaucipir in an Avid-sponsored study to augment the calculation of radiation dosimetry estimates.

Key facts

Study ID

NCT02336360

Run by

Avid Radiopharmaceuticals

People needed

6

Starts

2015-01-01

Expected to finish

2015-06-01

Last updated by the study team

2020-08-11

Who can join

Age: any. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Subjects who passed screening in an Avid-sponsored study in which flortaucipir will be administered

You may not qualify if…

• Subjects who have withdrawn informed consent
• Investigator or sponsor believes it is in the best interest of the subject to be removed from the trials

Where it is running

• Molecular NeuroImaging — New Haven, Connecticut, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.